|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Audentes Therapeutics, Inc. (BOLD) |
|
|
$59.97 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
45,860,000 |
| Market
Cap: |
2.75(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$59.97 - $59.97 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Patterson Matthew R |
Chief Executive Officer |
• • – |
2019-12-05 |
4 |
D |
$59.21 |
$116,881 |
D/D |
(1,974) |
111,420 |
|
- |
|
| Patterson Matthew R |
Chief Executive Officer |
• • – |
2019-11-08 |
4 |
AS |
$30.00 |
$432,780 |
D/D |
(14,426) |
113,394 |
|
- |
|
| Patterson Matthew R |
Chief Executive Officer |
• • – |
2019-11-08 |
4 |
OE |
$9.50 |
$137,047 |
D/D |
14,426 |
127,820 |
|
- |
|
| Lange Louis G |
Director |
– • – |
2019-09-23 |
4 |
AS |
$32.18 |
$32,182 |
I/I |
(1,000) |
14,678 |
|
- |
|
| Lange Louis G |
Director |
– • – |
2019-09-23 |
4 |
AS |
$32.15 |
$321,616 |
D/D |
(10,000) |
275,799 |
|
- |
|
| Soloway Thomas P |
Executive Vice President, CFO |
• – – |
2019-09-05 |
4 |
D |
$31.02 |
$15,665 |
D/D |
(505) |
21,819 |
|
- |
|
| Holles Natalie C. |
President and COO |
• – – |
2019-09-05 |
4 |
D |
$31.02 |
$15,665 |
D/D |
(505) |
55,209 |
|
- |
|
| Patterson Matthew R |
Chief Executive Officer |
• • – |
2019-09-05 |
4 |
D |
$31.02 |
$61,233 |
D/D |
(1,974) |
113,394 |
|
- |
|
| Patterson Matthew R |
Chief Executive Officer |
• • – |
2019-08-12 |
4 |
AS |
$34.02 |
$680,835 |
D/D |
(20,000) |
115,368 |
|
- |
|
| Patterson Matthew R |
Chief Executive Officer |
• • – |
2019-08-12 |
4 |
OE |
$9.50 |
$190,000 |
D/D |
20,000 |
135,368 |
|
- |
|
| Conner Edward R. |
SVP, Chief Medical Officer |
• – – |
2019-07-15 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
30,000 |
|
- |
|
| Lange Louis G |
Director |
– • – |
2019-06-24 |
4 |
AS |
$37.89 |
$38,201 |
I/I |
(1,000) |
15,678 |
|
- |
|
| Lange Louis G |
Director |
– • – |
2019-06-24 |
4 |
AS |
$37.60 |
$755,413 |
D/D |
(20,000) |
285,799 |
|
- |
|
| Patterson Matthew R |
Chief Executive Officer |
• • – |
2019-06-05 |
4 |
D |
$37.31 |
$124,317 |
D/D |
(3,332) |
115,368 |
|
- |
|
| Prasad Suyash |
Senior VP & Chief Med Officer |
• – – |
2019-06-05 |
4 |
D |
$37.31 |
$28,244 |
D/D |
(757) |
17,479 |
|
- |
|
| Holles Natalie C. |
President and COO |
• – – |
2019-06-05 |
4 |
D |
$37.31 |
$37,646 |
D/D |
(1,009) |
55,714 |
|
- |
|
| Soloway Thomas P |
Executive Vice President, CFO |
• – – |
2019-06-05 |
4 |
D |
$37.31 |
$37,646 |
D/D |
(1,009) |
22,324 |
|
- |
|
| Meltz Mark A |
SVP, General Counsel |
• – – |
2019-03-28 |
4 |
A |
$0.00 |
$0 |
D/D |
37,333 |
37,333 |
|
- |
|
| Lange Louis G |
Director |
– • – |
2019-03-25 |
4 |
AS |
$35.94 |
$56,058 |
I/I |
(1,558) |
0 |
|
- |
|
| Lange Louis G |
Director |
– • – |
2019-03-25 |
4 |
AS |
$35.99 |
$720,015 |
D/D |
(20,000) |
305,799 |
|
- |
|
| Patterson Matthew R |
Chief Executive Officer |
• • – |
2019-02-25 |
4 |
AS |
$30.00 |
$630,000 |
D/D |
(21,000) |
118,700 |
|
- |
|
| Patterson Matthew R |
Chief Executive Officer |
• • – |
2019-02-25 |
4 |
OE |
$0.78 |
$22,020 |
D/D |
21,000 |
122,700 |
|
- |
|
| Prasad Suyash |
Senior VP & Chief Med Officer |
• – – |
2019-02-25 |
4 |
AS |
$30.06 |
$300,553 |
D/D |
(10,000) |
18,236 |
|
- |
|
| Prasad Suyash |
Senior VP & Chief Med Officer |
• – – |
2019-02-25 |
4 |
OE |
$0.79 |
$7,900 |
D/D |
10,000 |
28,236 |
|
- |
|
| Holles Natalie C. |
President and COO |
• – – |
2019-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
23,333 |
56,723 |
|
- |
|
162 Records found
|
|
Page 2 of 7 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
